Spinal Tech

Orthofix's BioStim segment was a primary driver in the company's net sales growth in the second quarter.

With the flurry of device company M&A activity, some analysts anticipate future spine deals to occur, according to The Street.

Plainsboro, N.J.-based Integra LifeSciences reported its financial results for the second quarter of 2016, ending June 30.

Cesca Therapeutics, a Rancho Cordova, Calif.-based autologous cell-based regenerative medicine company, released the study results on its technology for treating non-union fractures.

Xtant Medical reported its financial results for the second quarter of 2016, ended June 30th. 

Surgeons have used Vertical Spine's FIBRINET System technology in 1,000 cases.

Amendia is expanding its manufacturing facility in Marietta, Ga.

Corin Group signed an expanded distribution agreement with FX Solutions.

Pan Medical has just launched the InterV Flex.

Melbourne, Australia-based Mesoblast announced the 24-month results from its chronic low back pain product trial. The 100-patient randomized Phase 2 trial tested the company's allogenic mesenchymal precursor cells.